Publications
Detailed Information
Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Sejoong | - |
dc.contributor.author | Oh, Jieun | - |
dc.contributor.author | Kim, Suhnggwon | - |
dc.contributor.author | Chung, Wookyung | - |
dc.contributor.author | Kim, Sung Gyun | - |
dc.contributor.author | Oh, Kook-Hwan | - |
dc.contributor.author | Ahn, Curie | - |
dc.date.accessioned | 2012-05-30T07:14:27Z | - |
dc.date.available | 2012-05-30T07:14:27Z | - |
dc.date.issued | 2009-09 | - |
dc.identifier.citation | NEPHROLOGY DIALYSIS TRANSPLANTATION; Vol.24 9; 2899-2908 | ko_KR |
dc.identifier.issn | 0931-0509 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76625 | - |
dc.description.abstract | Methods. Ninety-one incident patients started CAPD for 12-month treatment with either LF (Balance (R), Fresenius, n = 48) or CF (CAPD/DPCA (R), Fresenius, n = 43). RRF, peritoneal solute transport rate and solute clearance were measured every 6 months. Results. LF had a significant effect on the change of glomerular filtration rate (GFR) (P = 0.048 by the mixed model). In per-protocol analysis, GFR in the LF group did not decrease over a 12-month period, while GFR in the control group significantly decreased (0.13 +/- 33.4 L/ week/1.73 m(2) for LF versus -13.6 +/- 19.4 L/week/1.73 m(2) for CF, P = 0.049). Subgroup analysis for patients with initial GFR of 2 mL/min/1.73 m(2) or above showed a significantly higher GFR for the LF group over the 12-month period. At Month 13, serum total CO(2) levels were higher and serum albumin levels were lower in the LF group. No differences between the two groups were observed for the C-reactive protein. Over the 12-month period, effluent cancer antigen-125 levels significantly increased in the LF group, compared with those of the CF group, while effluent interleukin-6 levels were not different between the two groups. Conclusion. Our study suggests that LF may better preserve RRF over the 12-month treatment period in incident CAPD patients. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | OXFORD UNIV PRESS | ko_KR |
dc.subject | end-stage renal disease | ko_KR |
dc.subject | residual renal function | ko_KR |
dc.subject | glucose degradation products | ko_KR |
dc.subject | peritoneal dialysis | ko_KR |
dc.subject | randomized controlled trials | ko_KR |
dc.title | Benefits of biocompatible PD fluid for preservation of residual renal function in incident CAPD patients: a 1-year study | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 김세중 | - |
dc.contributor.AlternativeAuthor | 오지은 | - |
dc.contributor.AlternativeAuthor | 김성권 | - |
dc.contributor.AlternativeAuthor | 정우경 | - |
dc.contributor.AlternativeAuthor | 안규리 | - |
dc.contributor.AlternativeAuthor | 김성균 | - |
dc.contributor.AlternativeAuthor | 오국환 | - |
dc.identifier.doi | 10.1093/ndt/gfp054 | - |
dc.citation.journaltitle | NEPHROLOGY DIALYSIS TRANSPLANTATION | - |
dc.description.citedreference | Oh KH, 2008, NEPHROL DIAL TRANSPL, V23, P2356, DOI 10.1093/ndt/gfm921 | - |
dc.description.citedreference | Fan SLS, 2008, KIDNEY INT, V73, P200, DOI 10.1038/sj.ki.5002574 | - |
dc.description.citedreference | Fang W, 2008, PERITON DIALYSIS INT, V28, P35 | - |
dc.description.citedreference | Schmitt CP, 2007, NEPHROL DIAL TRANSPL, V22, P2038, DOI 10.1093/ndt/gfm148 | - |
dc.description.citedreference | Szeto CC, 2007, NEPHROL DIAL TRANSPL, V22, P552, DOI 10.1093/ndt/gfl559 | - |
dc.description.citedreference | Brimble KS, 2006, J AM SOC NEPHROL, V17, P2591, DOI 10.1681/ASN.2006030194 | - |
dc.description.citedreference | Pecoits R, 2006, PERITON DIALYSIS INT, V26, P53 | - |
dc.description.citedreference | Martikainen TA, 2005, PERITON DIALYSIS INT, V25, P453 | - |
dc.description.citedreference | Justo P, 2005, DIABETES, V54, P2424 | - |
dc.description.citedreference | Lee HY, 2005, PERITON DIALYSIS INT, V25, P248 | - |
dc.description.citedreference | Piraino B, 2005, PERITON DIALYSIS INT, V25, P107 | - |
dc.description.citedreference | Konings CJ, 2005, KIDNEY INT, V67, P1190 | - |
dc.description.citedreference | Wang XX, 2004, KIDNEY INT, V66, P2315 | - |
dc.description.citedreference | Williams JD, 2004, KIDNEY INT, V66, P408 | - |
dc.description.citedreference | Smit W, 2003, PERITON DIALYSIS INT, V23, P440 | - |
dc.description.citedreference | Pecoits R, 2003, AM J KIDNEY DIS, V41, P1212, DOI 10.1016/S0272-6386(03)00353-6 | - |
dc.description.citedreference | Termorshuizen F, 2003, AM J KIDNEY DIS, V41, P1293, DOI 10.1016/S0272-6386(03)00362-7 | - |
dc.description.citedreference | Konings CJAM, 2003, KIDNEY INT, V63, P1556 | - |
dc.description.citedreference | Zeier M, 2003, KIDNEY INT, V63, P298 | - |
dc.description.citedreference | MONTENEGRO J, 2003, NEPHROL DIAL TRAN S4, V18, pS216 | - |
dc.description.citedreference | Schrier R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018407.60002.B9 | - |
dc.description.citedreference | Paniagua R, 2002, J AM SOC NEPHROL, V13 | - |
dc.description.citedreference | Mortier S, 2002, J AM SOC NEPHROL, V13, P480 | - |
dc.description.citedreference | Bargman JM, 2001, J AM SOC NEPHROL, V12, P2158 | - |
dc.description.citedreference | Rippe B, 2001, KIDNEY INT, V59, P348 | - |
dc.description.citedreference | Cooker LA, 2001, PERITON DIALYSIS INT, V21, pS102 | - |
dc.description.citedreference | Singhal MK, 2000, PERITON DIALYSIS INT, V20, P429 | - |
dc.description.citedreference | Witowski J, 2000, J AM SOC NEPHROL, V11, P729 | - |
dc.description.citedreference | Combet S, 2000, J AM SOC NEPHROL, V11, P717 | - |
dc.description.citedreference | HUFNAGEL G, 1999, NEPHROL DIAL TRANSPL, V14, P1224 | - |
dc.description.citedreference | Feriani M, 1998, KIDNEY INT, V54, P1731 | - |
dc.description.citedreference | MILLAR DJ, 1998, ADV PERIT D, V14, P191 | - |
dc.description.citedreference | Hiroshige K, 1996, PERITON DIALYSIS INT, V16, P307 | - |
dc.description.citedreference | DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353 | - |
dc.description.citedreference | VISSER CE, 1995, NEPHROL DIAL TRANSPL, V10, P64 | - |
dc.description.citedreference | VLASSARA H, 1994, P NATL ACAD SCI USA, V91, P11704 | - |
dc.description.citedreference | BLAKE PG, 1993, J AM SOC NEPHROL, V3, P1501 | - |
dc.description.citedreference | DUBOIS D, 1989, NUTRITION, V5, P303 | - |
dc.description.citedreference | DUBOIS D, 1989, NUTRITION, V5, P312 | - |
dc.description.citedreference | STEINHAUER HB, 1986, KIDNEY INT, V29, P584 | - |
dc.description.citedreference | WATSON PE, 1980, AM J CLIN NUTR, V33, P27 | - |
dc.description.tc | 17 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.